CS221505B2 - Method of making the compounds of the type of n-acetylmuramyle - Google Patents

Method of making the compounds of the type of n-acetylmuramyle Download PDF

Info

Publication number
CS221505B2
CS221505B2 CS793866A CS386679A CS221505B2 CS 221505 B2 CS221505 B2 CS 221505B2 CS 793866 A CS793866 A CS 793866A CS 386679 A CS386679 A CS 386679A CS 221505 B2 CS221505 B2 CS 221505B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
group
dipeptide
defined above
compound
Prior art date
Application number
CS793866A
Other languages
Czech (cs)
English (en)
Inventor
Pierre Lefrancier
Monique Parant
Francoise Audibert
Louis Chedid
Jean Choay
Edgar Lederer
Original Assignee
Anvar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anvar filed Critical Anvar
Publication of CS221505B2 publication Critical patent/CS221505B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CS793866A 1978-06-05 1979-06-05 Method of making the compounds of the type of n-acetylmuramyle CS221505B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7816793A FR2428051A1 (fr) 1978-06-05 1978-06-05 Nouveaux composes du type muramyl-peptide et medicaments les contenant

Publications (1)

Publication Number Publication Date
CS221505B2 true CS221505B2 (en) 1983-04-29

Family

ID=9209095

Family Applications (1)

Application Number Title Priority Date Filing Date
CS793866A CS221505B2 (en) 1978-06-05 1979-06-05 Method of making the compounds of the type of n-acetylmuramyle

Country Status (21)

Country Link
US (1) US4693998A (ru)
EP (1) EP0006068B1 (ru)
JP (1) JPS55392A (ru)
AR (1) AR228240A1 (ru)
AT (1) ATE4719T1 (ru)
AU (1) AU536516B2 (ru)
CA (1) CA1249700A (ru)
CS (1) CS221505B2 (ru)
DD (1) DD145274A5 (ru)
DE (1) DE2966178D1 (ru)
DK (1) DK150147C (ru)
EG (1) EG14154A (ru)
ES (1) ES481785A1 (ru)
FR (1) FR2428051A1 (ru)
HU (1) HU184041B (ru)
IL (1) IL57476A (ru)
MA (1) MA18474A1 (ru)
OA (1) OA06274A (ru)
PL (1) PL123483B1 (ru)
PT (1) PT69725A (ru)
SU (2) SU1326197A3 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
JPS5784223A (en) * 1980-11-13 1982-05-26 Nissan Motor Co Ltd Vibration absorber of vehicle
FR2529463B1 (fr) * 1982-07-05 1986-01-10 Centre Nat Rech Scient Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus
DE3367596D1 (en) * 1982-07-23 1987-01-02 Ciba Geigy Ag Muramyl peptides and method for their preparation
US5134230A (en) * 1988-03-02 1992-07-28 Daiichi Pharmaceutical Co., Ltd. 2-Deoxy-2-aminoglucopyranoside derivatives
JPH0832638B2 (ja) * 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
WO2000068251A1 (en) 1999-05-07 2000-11-16 The University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
CN109406709B (zh) * 2018-12-27 2020-11-10 福建省中医药研究院(福建省青草药开发服务中心） 一种太子参药材中氨基酸类成分的薄层鉴别方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2292486A1 (fr) * 1974-07-01 1976-06-25 Anvar Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de microbacteries et autres micro-organismes
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
FR2369292A1 (fr) * 1976-11-02 1978-05-26 Anvar Agents adjuvants immunit
GB1573126A (en) * 1976-03-10 1980-08-13 Anvar Immunising and anti-infectious adjuvant agents comprising peptide derivatives of muramic acid
US4153684A (en) * 1976-03-10 1979-05-08 Agence Nationale De Valorisation De La Recherche (Anvar) Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives
FR2355505A1 (fr) * 1976-06-24 1978-01-20 Anvar Nouvel agent adjuvant immunitaire
FR2358159A1 (fr) * 1976-07-16 1978-02-10 Anvar Le diamide de l'acide 2-(2-acetamido-2-deoxy-3 - o-d-glucopyranosyl) - d-propionyl-l-alanyl-d-glutamique et medicaments le contenant
FR2368282A1 (fr) * 1976-10-22 1978-05-19 Anvar Adjuvant immunologique constitue par le p-amino-phenyl de n-acetyl-muramyl-l-alanyl-d-isoglutamine
CA1138436A (en) * 1978-02-24 1982-12-28 Gerhard Baschang Process for the manufacture of novel antigens

Also Published As

Publication number Publication date
PL123483B1 (en) 1982-10-30
DK150147C (da) 1988-01-18
JPH0233720B2 (ru) 1990-07-30
AU536516B2 (en) 1984-05-10
US4693998A (en) 1987-09-15
DD145274A5 (de) 1980-12-03
FR2428051A1 (fr) 1980-01-04
JPS55392A (en) 1980-01-05
ATE4719T1 (de) 1983-10-15
EP0006068A3 (en) 1980-01-09
PT69725A (fr) 1979-07-01
ES481785A1 (es) 1980-02-16
AU4775679A (en) 1979-12-13
AR228240A1 (es) 1983-02-15
MA18474A1 (fr) 1979-12-31
CA1249700A (en) 1989-01-31
FR2428051B1 (ru) 1981-12-04
IL57476A0 (en) 1979-10-31
EP0006068A2 (fr) 1979-12-12
DE2966178D1 (en) 1983-10-27
SU1326197A3 (ru) 1987-07-23
EP0006068B1 (fr) 1983-09-21
EG14154A (en) 1983-09-30
SU1346046A3 (ru) 1987-10-15
DK150147B (da) 1986-12-15
HU184041B (en) 1984-06-28
DK229479A (da) 1979-12-06
OA06274A (fr) 1981-06-30
IL57476A (en) 1984-06-29
PL216102A1 (ru) 1980-03-24

Similar Documents

Publication Publication Date Title
US4855283A (en) Novel pharmaceutically active N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas
US4323559A (en) Compounds derived from N-acetyl-nor-muramyl-L-alanyl-D-isoglutamic acid and other compounds and biologically active compositions containing such compounds
FI83524B (fi) Foerfarande foer framstaellning av farmakologiskt verkande n-/n-alkanoyl-s-(2,3-dialkanoyloxi-propyl) kysteinyl/-peptider.
FI64164C (fi) Foerfarande foer framstaellning av 2-(2-acylamino-2-desoxi-(d)-glukosyl-3-0)-alkankarboxylsyrapeptid-derivat
US4396607A (en) Muramyl peptide derivatives and pharmaceutical compositions
IL132739A (en) Substances that affect the immune system and their supplements, which are aminoalkyl glucosamidide phosphate compounds that are converted by many nobles, vaccines and pharmaceuticals that contain them
US4461761A (en) Oligomers of compounds of the muramyl-peptide type and medicaments containing them
JPS58208237A (ja) 免疫原活性を付与されたハプテンとムラムル―ペプチドとの組成物
JP3821305B2 (ja) 細胞障害性ｔリンパ球誘導リポペプチドおよびワクチン
US4427659A (en) Muramyl peptide substituted on a peptide nitrogen and medicaments containing the same
JP2006514981A (ja) Ｇｐ１２０特異抗原、その結合体；その調製と使用のための方法
CS221505B2 (en) Method of making the compounds of the type of n-acetylmuramyle
US5416070A (en) Composition for macrophage activation
US4362716A (en) Dipeptides, their preparation and compositions containing them
USRE35706E (en) Lipophila derivatives of muramylpeptides having properties of activating macrophages and compositions containing them
US20190231860A1 (en) Synthetic lipopeptide vaccines and immunotherapeutics
JP2662951B2 (ja) Ｄ．２５ポリサッカライドから得られる誘導体
KR830002059B1 (ko) 멀아밀-펲타이드형태인 신규 화합물의 제조방법
GB1584791A (en) Muromyl peptide immunological adjuvants
JPS61275299A (ja) デオキシムラミルジペプチド誘導体
IE48735B1 (en) Muramyl-peptide ester compounds and their application in pharmaceutical compositions and laboratory reagents
IE49617B1 (en) Novel compounds of the muramyl-peptide type and medicaments containing them
CZ296720B6 (cs) Lipofilní analogy N-acetylnormuramoyl-L-alfa-aminobutanoyl-D-izoglutaminu s imunostimulacní aktivitou